From: Cost-effectiveness analysis of flucytosine as induction therapy in the treatment of cryptococcal meningitis in HIV-infected adults in South Africa
Treatment arm
LY
QALY
Cost (USD)
1-week AmBd/5Flu
8.67
8.15
1873
2-week AmBd/Flu (SC)
11.10
10.44
2208
Oral 5FC/Flu
12.42
11.69
2472
1-week AmBd/5FC
16.01
15.08
2698
2-week AmBd/5FC
11.99
11.28
2731